Analysis of Pathogen Detection Data in 898 Pediatric Patients Hospitalized with Community-Acquired Pneumonia
DOI:
https://doi.org/10.54097/2rgcnh23Keywords:
Pediatric Community-acquired Pneumonia, Respiratory Pathogen Detection, Epidemiology, Mixed Infections, Mycoplasma Pneumoniae, Seasonal VariationAbstract
Introduction: The prevalence of community-acquired pneumonia (CAP) in pediatric patients has seen significant changes following the lifting of COVID-19 restrictions. This study examines the epidemiology and pathogen detection in children hospitalized with CAP at Beijing New Century Children's Hospital throughout 2023. Objective: To analyze the pathogen detection rates and distribution characteristics among 898 pediatric CAP patients admitted during 2023, focusing on age-related and seasonal variations. Methods: This retrospective study included 898 pediatric patients diagnosed with CAP between January 1 and December 31, 2023. Respiratory pathogen detection was performed using a combination of antigen detection kits, nucleic acid testing, and bacterial culture. The data were analyzed for pathogen distribution across different age groups and seasons. Results: Of the 898 CAP cases, pathogens were detected in 703 cases (78.3%). Mycoplasma pneumoniae was the most frequently identified pathogen (44.1%), with detection rates increasing significantly with age, particularly in school-aged children. Viral pathogens were detected in 42.7% of cases, with Respiratory Syncytial Virus (32.4%) being the most prevalent. Bacterial pathogens were identified in 49.5% of cases, with Streptococcus pneumoniae (34.1%) and Haemophilus influenzae (33.0%) being the most common. Mixed infections were observed in 64.4% of cases, with a higher prevalence in older children and during the autumn and winter seasons. Conclusions: The study highlights significant age and seasonal variations in pathogen distribution among pediatric CAP patients. Mycoplasma pneumoniae was more common in older children and during autumn, while bacterial infections peaked in winter. The findings emphasize the need for age and season-specific strategies in managing pediatric CAP and suggest that comprehensive diagnostic approaches are crucial to accurately identify the causative pathogens.
Downloads
References
[1] Rees CA, Kuppermann N, Florin TA. Community-Acquired Pneumonia in Children. Pediatr Emerg Care (2023) 39:968–976. doi: 10.1097/PEC.0000000000003070.
[2] Williams DJ, Shah SS. Community-Acquired Pneumonia in the Conjugate Vaccine Era. J Pediatr Infect Dis Soc (2012) 1:314–328. doi: 10.1093/jpids/pis101.
[3] Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, Prieto-Merino D, Cousens S, Black RE, Liu L. Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health (2022) 6:106–115. doi: 10.1016/S2352-4642(21)00311-4.
[4] He C, Liu L, Chu Y, Perin J, Dai L, Li X, Miao L, Kang L, Li Q, Scherpbier R, et al. National and subnational all-cause and cause-specific child mortality in China, 1996–2015: a systematic analysis with implications for the Sustainable Development Goals. Lancet Glob Health (2017) 5:e186–e197. doi: 10.1016/S2214-109X(16)30334-5.
[5] Hampl W, Mertens T. “Viral pathogens and epidemiology, detection, therapy and resistance.,” Community-Acquired Pneumonia. Basel: Birkhäuser Basel (2007). p. 27–56 doi: 10. 1007/ 978-3-7643-7563-8_3.
[6] Walter JM. Other Respiratory Viruses as a Cause of Community-Acquired Pneumonia. Semin Respir Crit Care Med (2020) 41:579–591. doi: 10.1055/s-0040-1710537.
[7] El Sayed Zaki M, Goda T. Clinico-pathological study of atypical pathogens in community-acquired pneumonia: a prospective study. J Infect Dev Ctries (2009) 3:199–205. doi: 10.3855/jidc.36.
[8] Gleason PP. The Emerging Role of Atypical Pathogens in Community‐Acquired Pneumonia. Pharmacother J Hum Pharmacol Drug Ther (2002) 22: doi: 10.1592/phco. 22.2. 2S. 33130.
[9] Savelyeva EI, Gadetskaya SG, Korsunsky AA. Features of the course of community-acquired pneumonia in children before and during the COVID-19 pandemic. Russ Pediatr J (2022) 25:164–168. doi: 10.46563/1560-9561-2022-25-3-164-168.
[10] Lamrani Hanchi A, Guennouni M, Ben Houmich T, Echchakery M, Draiss G, Rada N, Younous S, Bouskraoui M, Soraa N. Changes in the Epidemiology of Respiratory Pathogens in Children during the COVID-19 Pandemic. Pathogens (2022) 11:1542. doi: 10.3390/pathogens11121542.
[11] Tan JY, Conceicao EP, Wee LE, Sim XYJ, Venkatachalam I. COVID-19 public health measures: a reduction in hospital admissions for COPD exacerbations. Thorax (2021) 76:512–513. doi: 10.1136/thoraxjnl-2020-216083.
[12] Achangwa C, Park H, Ryu S, Lee M-S. Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020–2021. Viruses (2022) 14:1071. doi: 10.3390/v14051071.
[13] Guo C, Wu J-Y. Pathogen Discovery in the Post-COVID Era. Pathogens (2024) 13:51. doi: 10.3390/pathogens13010051.
[14] Sharma B, Vyas N. Healthcare in the Aftermath of COVID-19: Charting a Course for the Future. 2023 International Conference on Circuit Power and Computing Technologies (ICCPCT). Kollam, India: IEEE (2023). p. 1280–1285 doi: 10.1109/ICCPCT58313.2023.10244828.
[15] Maison N, Peck A, Illi S, Meyer-Buehn M, Von Mutius E, Hübner J, Von Both U. The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections. Infection (2022) 50:519–524. doi: 10.1007/s15010-022-01756-4.
[16] Hodjat P, Christensen PA, Subedi S, Bernard DW, Olsen RJ, Long SW. The rapid reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-19 restrictions. (2021) doi: 10.1101/2021.05.27.21257940.
[17] Cassone M, Mantey J, Gontjes KJ, Lansing BJ, Gibson KE, Wang J, Mody L. Seasonal Patterns in Incidence and Antimicrobial Resistance of Common Bacterial Pathogens in Nursing Home Patients and Their Rooms. Front Public Health (2021) 9:671428. doi: 10.3389/fpubh.2021.671428.
[18] Litwin CM, Bosley JG. Seasonality and prevalence of respiratory pathogens detected by multiplex PCR at a tertiary care medical center. Arch Virol (2014) 159:65–72. doi: 10.1007/s00705-013-1794-4.
[19] Pneumonia and Respiratory Disease Study Group of Korean Academy of Pediatric Allergy and Respiratory Disease, Lee E, Kim C-H, Lee YJ, Kim H-B, Kim B-S, Kim HY, Kim Y, Kim S, Park C, et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect Dis (2020) 20:132. doi: 10.1186/s12879-020-4810-9.
[20] Cantais A, Mory O, Pillet S, Verhoeven PO, Bonneau J, Patural H, Pozzetto B. Epidemiology and microbiological investigations of community-acquired pneumonia in children admitted at the emergency department of a university hospital. J Clin Virol (2014) 60:402–407. doi: 10.1016/j. jcv. 2014. 05. 006.
[21] Mardian Y, Menur Naysilla A, Lokida D, Farida H, Aman AT, Karyana M, Lukman N, Kosasih H, Kline A, Lau C-Y. Approach to Identifying Causative Pathogens of Community-Acquired Pneumonia in Children Using Culture, Molecular, and Serology Tests. Front Pediatr (2021) 9:629318. doi: 10.3389/fped.2021.629318.
[22] Gerber J, Grundmeier R, Hamilton KW, Hicks L, Neuhauser MM, Frager N, Menon M, Kratz E, Jaskowiak A, Cressman L, et al. 151. An Electronic Algorithm to Better Target Antimicrobial Stewardship Program (ASP) Efforts for Children Hospitalized with Community-Acquired Pneumonia (CAP). Open Forum Infect Dis (2020) 7:S85–S86. doi: 10. 1093/ ofid/ofaa439.196.
[23] Christie L C, Sherene S, Catherine R M, Edmund H, Jeannene S, Christy B. Evaluation of Empiric Management of Pediatric Community-Acquired Pneumonia. Sch J Emerg Med Crit Care (2018) 2: doi: 10.36959/592/381.
[24] Tannous R, Haddad RN, Torbey P-H. Management of Community-Acquired Pneumonia in Pediatrics: Adherence to Clinical Guidelines. Front Pediatr (2020) 8:302. doi: 10. 3389/ fped. 2020.00302.
[25] CAP-PRI Working Group, Usonis V, Ivaskevicius R, Diez-Domingo J, Esposito S, Falup-Pecurariu OG, Finn A, Rodrigues F, Spoulou V, Syrogiannopoulos GA, et al. Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines. Pneumonia (2016) 8:5. doi: 10.1186/s41479-016-0005-y.
[26] Fong-Ponce BG. Neumonía adquirida en la comunidad: Identificando las comorbilidades como factores de riesgo. Kompass Neumol (2020) 2:24–25. doi: 10.1159/000504867.
[27] Williams DJ, Shah SS, Myers A, Hall M, Auger K, Queen MA, Jerardi KE, McClain L, Wiggleton C, Tieder JS. Identifying Pediatric Community-Acquired Pneumonia Hospitalizations: Accuracy of Administrative Billing Codes. JAMA Pediatr (2013) 167:851. doi: 10.1001/jamapediatrics.2013.186.
[28] Tokuno O, Fujiwara M, Nakajoh Y, Yamanouchi S, Adachi M, Ikeda A, Kitayama S, Takahashi T, Kase T, Kinoshita S, et al. Comparison of Detection Sensitivity in Rapid-diagnosis Influenza Virus Kits. Kansenshogaku Zasshi (2009) 83:525–533. doi: 10.11150/kansenshogakuzasshi.83.525.
[29] Akaishi Y, Matsumoto T, Harada Y, Hirayama Y. Evaluation of the rapid influenza detection tests GOLD SIGN FLU and Quick Navi-Flu for the detection of influenza A and B virus antigens in adults during the influenza season. Int J Infect Dis (2016) 52:55–58. doi: 10.1016/j.ijid.2016.10.002.
[30] Kuoppa Y, Boman J, Scott L, Kumlin U, Eriksson I, Allard A. Quantitative Detection of Respiratory Chlamydia pneumoniae Infection by Real-Time PCR. J Clin Microbiol (2002) 40: 2273–2274. doi: 10.1128/JCM.40.6.2273-2274.2002.
[31] Kehl SC, Kumar S. Utilization of Nucleic Acid Amplification Assays for the Detection of Respiratory Viruses. Clin Lab Med (2009) 29:661–671. doi: 10.1016/j.cll.2009.07.008.
[32] Anis E, Hawkins IK, Ilha MRS, Woldemeskel MW, Saliki JT, Wilkes RP. Evaluation of Targeted Next-Generation Sequencing for Detection of Bovine Pathogens in Clinical Samples. J Clin Microbiol (2018) 56:e00399-18. doi: 10. 1128/ JCM.00399-18.
[33] Parker J, Chen J. Application of next generation sequencing for the detection of human viral pathogens in clinical specimens. J Clin Virol (2017) 86:20–26. doi: 10.1016/j.jcv.2016.11.010.
[34] Stoltzfus J. Student’s t-test for independent samples. Int J Acad Med (2015) 1:27. doi: 10.4103/2455-5568.172708.
[35] Machin D, Campbell MJ, Tan SB, Tan SH. Sample Sizes for Clinical, Laboratory and Epidemiology Studies. 1st ed. Wiley. (2018). doi: 10.1002/9781118874905.
[36] Li X, Chen B, Zhang S, Li X, Chang J, Tang Y, Wu Y, Lu X. Rapid Detection of Respiratory Pathogens for Community-Acquired Pneumonia by Capillary Electrophoresis-Based Multiplex PCR. SLAS Technol (2019) 24:105–116. doi: 10.1177/2472630318787452.
[37] Farnaes L, Wilke J, Ryan Loker K, Bradley JS, Cannavino CR, Hong DK, Pong A, Foley J, Coufal NG. Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management. Diagn Microbiol Infect Dis (2019) 94:188–191. doi: 10.1016/j.diagmicrobio.2018.12.016.
[38] Schlaberg R, Queen K, Simmon K, Tardif K, Stockmann C, Flygare S, Kennedy B, Voelkerding K, Bramley A, Zhang J, et al. Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology. J Infect Dis (2017) 215:1407–1415. doi: 10.1093/infdis/jix148.
[39] Diaz MH, Winchell JM. The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma pneumoniae. Front Microbiol (2016) 7: doi: 10.3389/fmicb.2016.00232.
[40] De Waele JJ, Boelens J. Antimicrobial stewardship and molecular diagnostics: a symbiotic approach to combating resistance in the ED and ICU. Curr Opin Crit Care (2024) 30:231–238. doi: 10.1097/MCC.0000000000001154.
[41] Goldenberg S. Molecular-based diagnostics, including future trends. Medicine (Baltimore) (2017) 45:645–648. doi: 10.1016/j.mpmed.2017.07.004.
[42] Rueda ZV, Aguilar Y, Maya MA, López L, Restrepo A, Garcés C, Morales O, Roya-Pabón C, Trujillo M, Arango C, et al. Etiology and the challenge of diagnostic testing of community-acquired pneumonia in children and adolescents. BMC Pediatr (2022) 22:169. doi: 10.1186/s12887-022-03235-z.
[43] Florin TA, French B, Zorc JJ, Alpern ER, Shah SS. Variation in Emergency Department Diagnostic Testing and Disposition Outcomes in Pneumonia. Pediatrics (2013) 132:237–244. doi: 10.1542/peds.2013-0179.
[44] Sobieszczańska B, Kasprzykowska U, Duda-Madej A, Secewicz J, Marciniak J. Relevance of Serology for Mycoplasma Pneumoniae Infection Among Children with Persistent Cough. Adv Clin Exp Med (2014) 23:185–190. doi: 10.17219/acem/37046.
[45] Meyer Sauteur PM, Seiler M, Trück J, Unger WWJ, Paioni P, Relly C, Staubli G, Haas T, Gysin C, M. Bachmann L, et al. Diagnosis of Mycoplasma pneumoniae Pneumonia with Measurement of Specific Antibody-Secreting Cells. Am J Respir Crit Care Med (2019) 200:1066–1069. doi: 10.1164/rccm.201904-0860LE.
[46] Bernotienė R, Palinauskas V, Iezhova T, Murauskaitė D, Valkiūnas G. Avian haemosporidian parasites (Haemosporida): A comparative analysis of different polymerase chain reaction assays in detection of mixed infections. Exp Parasitol (2016) 163:31–37. doi: 10.1016/j.exppara.2016.01.009.
[47] Gupta B, Gupta P, Sharma A, Singh V, Dash AP, Das A. High proportion of mixed‐species Plasmodium infections in India revealed by PCR diagnostic assay. Trop Med Int Health (2010) 15:819–824. doi: 10.1111/j.1365-3156.2010. 02549.x.
[48] NikNadia N, Sam I-C, Rampal S, WanNorAmalina W, NurAtifah G, Verasahib K, Ong CC, MohdAdib M, Chan YF. Cyclical Patterns of Hand, Foot and Mouth Disease Caused by Enterovirus A71 in Malaysia. PLoS Negl Trop Dis (2016) 10: e0004562. doi: 10.1371/journal.pntd.0004562.
[49] Siffel C, Alverson CJ, Correa A. Analysis of seasonal variation of birth defects in Atlanta. Birt Defects Res A Clin Mol Teratol (2005) 73:655–662. doi: 10.1002/bdra.20207.
[50] Sofianos C, Christofides EA, Phiri SE. Seasonal Variation of Orofacial Clefts. J Craniofac Surg (2018) 29:368–371. doi: 10.1097/SCS.0000000000004226.
[51] Loens K, Van Heirstraeten L, Malhotra-Kumar S, Goossens H, Ieven M. Optimal Sampling Sites and Methods for Detection of Pathogens Possibly Causing Community-Acquired Lower Respiratory Tract Infections. J Clin Microbiol (2009) 47:21–31. doi: 10.1128/JCM.02037-08.
[52] Onwuchekwa C, Edem B, Williams V, Olujuwon I, Jallow M, Sanyang B, Verdonck K. Systematic review and meta-analysis on the etiology of bacterial pneumonia in children in sub-Saharan Africa. J Public Health Afr (2022) 13:16. doi: 10.4081/jphia.2022.2151.
[53] Garg I, Shekhar R, Sheikh AB, Pal S. Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections. Infect Dis Rep (2022) 14:558–568. doi: 10.3390/ idr 14040059.
[54] Chuang Y-C, Lin K-P, Wang L-A, Yeh T-K, Liu P-Y. The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review. Infect Drug Resist (2023) Volume 16:661–675. doi: 10.2147/IDR.S396434.
[55] Dagan R, Leibovitz E, Greenberg D, Bakaletz L, Givon-Lavi N. Mixed Pneumococcal–Nontypeable Haemophilus influenzae Otitis Media Is a Distinct Clinical Entity with Unique Epidemiologic Characteristics and Pneumococcal Serotype Distribution. J Infect Dis (2013) 208:1152–1160. doi: 10.1093/infdis/jit289.
[56] Versteegh FGA, Weverling GJ, Peeters MF, Wilbrink B, Veenstra-van Schie MTM, Van Leeuwen-Gerritsen JM, Mooi-Kokenberg EANM, Schellekens JFP, Roord JJ. Community-acquired pathogens associated with prolonged coughing in children: a prospective cohort study. Clin Microbiol Infect (2005) 11:801–807. doi: 10.1111/j.1469-0691.2005. 01234.x.
[57] Božič A, Kanduč M. Relative humidity in droplet and airborne transmission of disease. J Biol Phys (2021) 47:1–29. doi: 10.1007/s10867-020-09562-5.
[58] Numminen E, Chewapreecha C, Turner C, Goldblatt D, Nosten F, Bentley SD, Turner P, Corander J. Climate induces seasonality in pneumococcal transmission. Sci Rep (2015) 5:11344. doi: 10.1038/srep11344.
[59] Zhao Y, Lu R, Shen J, Xie Z, Liu G, Tan W. Comparison of viral and epidemiological profiles of hospitalized children with severe acute respiratory infection in Beijing and Shanghai, China. BMC Infect Dis (2019) 19:729. doi: 10.1186/s12879-019-4385-5.
[60] Zhang T, Li A, Lyu M, Chen M, Huang F, Wu J. Detection of respiratory viral and bacterial pathogens causing pediatric community‐acquired pneumonia in Beijing using real‐time PCR. Chronic Dis Transl Med (2015) 1:110–116. doi: 10.1016/j.cdtm.2015.06.002.
[61] Lode H, Schaberg T, Raffenberg M, Mauch H. Diagnostic problems in lower respiratory tract infections. J Antimicrob Chemother (1993) 32:29–37. doi: 10.1093/jac/32.suppl_A.29.
[62] Claassen-Weitz S, Lim KYL, Mullally C, Zar HJ, Nicol MP. The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children: a systematic review and meta-analysis. Clin Microbiol Infect (2021) 27:1262–1270. doi: 10.1016/j.cmi. 2021. 05.034.
[63] Miller S, Chiu C. The Role of Metagenomics and Next-Generation Sequencing in Infectious Disease Diagnosis. Clin Chem (2021) 68:115–124. doi: 10.1093/clinchem/hvab173.
[64] Filkins LM, Bryson AL, Miller SA, Mitchell SL. Navigating Clinical Utilization of Direct-from-Specimen Metagenomic Pathogen Detection: Clinical Applications, Limitations, and Testing Recommendations. Clin Chem (2020) 66:1381–1395. doi: 10.1093/clinchem/hvaa183.
[65] Dworsky ZD, Lee B, Ramchandar N, Rungvivatjarus T, Coufal NG, Bradley JS. Impact of Cell-Free Next-Generation Sequencing on Management of Pediatric Complicated Pneumonia. Hosp Pediatr (2022) 12:377–384. doi: 10.1542/ hpeds. 2021-006361.
[66] Chi H, Huang Y-C, Liu C-C, Chang K-Y, Huang Y-C, Lin H-C, Chang L-Y, Ho Y-H, Tsao K-C, Mu J-J, et al. Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan. J Formos Med Assoc (2020) 119:1490–1499. doi: 10.1016/j. jfma. 2020. 07. 014.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.